Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.26 (
GSK
)
6,788
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Frizzled proteins, the receptors for Wnt ligands have seven hydrophobic transmembrane domains, a structural feature of G protein coupled receptors. Therefore a role for G proteins in the regulation of Wnt signaling has been proposed. Here I have used Xenopus oocytes to study the role of heterotrimeric G proteins in the regulation of
GSK
-3beta and beta-Catenin, two essential components of the canonical Wnt pathway. In these cells, general activators of G proteins such as GTPgamma-S and AlF4(-) increase beta-Catenin stability and decrease
GSK
-3beta mediated phosphorylation of the microtubule associated protein, Tau. Among several members of Galpha proteins tested, expression of a constitutively active mutant of Galphaq (GalphaqQL) led to a significant increase in accumulation of beta-Catenin. The stabilization of beta-Catenin mediated by Galphaq was reversed by a Galphaq specific inhibitor, Gp-antagonist 2A, but not by a specific blocking peptide for Galphas. Expression of GalphaqQL also inhibited
GSK
-3beta-mediated tau phosphorylation in Xenopus oocytes. These results support a role for the
Gq class
of G proteins in the regulation of Wnt/beta-Catenin signal transduction.
...
PMID:Activators of G proteins inhibit GSK-3beta and stabilize beta-Catenin in Xenopus oocytes. 1928 33